Covered recipient · General Payments record
ANDREA P LEE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,253.21
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $282.34 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amneal Pharmaceuticals LLC | $84.89 | 4 |
| HOSPIRA, INC. | $59.49 | 4 |
| ABBVIE INC. | $27.66 | 2 |
| ANI Pharmaceuticals, Inc. | $20.94 | 1 |
| Medtronic, Inc. | $20.72 | 1 |
| Acorda Therapeutics, Inc | $20.14 | 1 |
| ARGENX US, INC. | $17.91 | 1 |
| Merz Pharmaceuticals, LLC | $17.37 | 1 |
| ACADIA Pharmaceuticals Inc | $13.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.35 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104149908 | CMS |
| ABBVIE INC. | $13.31 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104149910 | CMS |
| ACADIA Pharmaceuticals Inc | $13.22 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147982019 | CMS |
| Acorda Therapeutics, Inc | $20.14 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142347644 | CMS |
| Amneal Pharmaceuticals LLC | $17.03 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139192818 | CMS |
| Amneal Pharmaceuticals LLC | $20.51 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139192820 | CMS |
| Amneal Pharmaceuticals LLC | $25.26 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139192822 | CMS |
| Amneal Pharmaceuticals LLC | $22.09 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139192824 | CMS |
| ANI Pharmaceuticals, Inc. | $20.94 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091155924 | CMS |
| ARGENX US, INC. | $17.91 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127529 | CMS |
| HOSPIRA, INC. | $18.19 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131031065 | CMS |
| HOSPIRA, INC. | $14.56 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131335900 | CMS |
| HOSPIRA, INC. | $13.10 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131476025 | CMS |
| HOSPIRA, INC. | $13.64 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131880697 | CMS |
| Medtronic, Inc. | $20.72 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117032030 | CMS |
| Merz Pharmaceuticals, LLC | $17.37 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137946501 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.